Characteristics | Reconstruction type | p-value | ||
---|---|---|---|---|
Implant* (n = 247) | Flap (n = 249) | |||
Age, years | 0.190 | |||
Average | 41 ± 8.73 | 43 ± 6.99 | ||
Diagnosis | 0.076 | |||
IDC | 164 | 172 | ||
DCIS | 46 | 50 | ||
ILD | 17 | 8 | ||
LCIS | 0 | 4 | ||
Mixed | 11 | 8 | ||
Others | 9 | 7 | ||
Mastectomy type | 0.151 | |||
TM | 115 | 107 | ||
SSM | 64 | 84 | ||
NSM | 68 | 58 | ||
Excised breast mass, gram | 0.264 | |||
Average | 367 ± 191.63 | 409 ± 510.13 | ||
Lymph node status | 0.782 | |||
N0 | 180 | 171 | ||
N1 | 43 | 51 | ||
N2 | 16 | 18 | ||
N3 | 8 | 9 | ||
AJCC Stage | 0.278 | |||
0 | 47 | 57 | ||
IA | 99 | 82 | ||
IB | 1 | 0 | ||
IIA | 49 | 53 | ||
IIB | 24 | 26 | ||
IIIA | 20 | 19 | ||
IIIB | 0 | 3 | ||
IIIC | 7 | 9 | ||
Chemotherapy | 0.647 | |||
none | 111 | 117 | ||
perioperative | 136 | 132 | ||
Radiotherapy | 0.702 | |||
none | 195 | 200 | ||
adjuvant | 51 | 48 | ||
Nuclear grade, no. (%) | 0.487 | |||
1 | 4 | 4 | ||
2 | 101 | 84 | ||
3 | 94 | 100 | ||
Histological grade, no. (%) | 0.896 | |||
1 | 16 | 14 | ||
2 | 104 | 95 | ||
3 | 74 | 74 | ||
ER, no. (%) | 0.462 | |||
Negative | 49 | 43 | ||
Positive | 198 | 206 | ||
PR, no. (%) | 0.952 | |||
Negative | 76 | 76 | ||
Positive | 171 | 173 | ||
HER2, no. (%) | 0.128 | |||
Negative | 174 | 193 | ||
Positive | 56 | 44 | ||
Ki67, no. (%) | 0.014 | |||
< 10% | 198 | 174 | ||
≥10% | 48 | 71 |